| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213545 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 33 Pages |
Abstract
These data demonstrate that targeting PI4K IIIα using an anti-HCV agent is a viable approach to enhance the therapeutic efficacy of radiation therapy in various human cancers, such as glioma, breast, and hepatocellular carcinoma.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jeanny MD, PhD, Dan Hyo MS, Ji Min BS, Young Hee MD, Yeo Hyun PhD, Hong-Gyun MD, PhD, Kyung Hwan MD, PhD, In Ah MD, PhD,